Preparing for Transition from Life Sciences PE to Long/Short Hedge Fund

Hey all,

I’m currently a 2nd-year associate on a life sciences royalty team in private equity. I have a science undergraduate degree, followed by an MBA and CFA. I've done a few years in banking, both full-time and through internships, and I'm quite confident with my modeling skills.

Right now, I do enjoy my role, especially attending healthcare conferences and doing scientific and financial due diligence. My focus is mainly on commercialized assets and a few pre-approval projects, with analysis often taking several weeks. However, I'm looking for something new and more fast-paced with higher earning potential, so I'm considering transitioning to a life sciences long/short hedge fund. I understand the risks involved but am excited about the challenge. I've had conversations with a few recruiters and members of these firms and they always probe my interest in a transition to their L/S firm but I want to make sure I'm prepared since I know just because I've done well in the royalty side doesn't mean the L/S side will be the same

I know hedge funds require more rapid idea generation and analysis for every meeting, which is quite different from the more extended analysis cycle I'm used to.

Questions:

  1. How can I prepare myself over the next year to transition to a long/short investing role?
  2. What type of analysis should I focus on to become a better equities investor?
  3. What should I be reading, and who should I be following to stay updated on market trends and improve my investing skills?
  4. Any specific resources or strategies you recommend for someone coming from a PE background to adapt to the hedge fund environment?

Any advice or insights would be greatly appreciated!

Thanks!

4 Comments
 

All of the questions they have listed are generic to any hedge fund. There are also threads on healthcare/biotech fund/pods too. 
 

 

Repellendus nostrum natus quasi quasi. Qui quasi id officiis ut distinctio voluptate repellat consequatur. Aut debitis vero voluptas provident saepe. Eaque magnam odit voluptatem sequi quo fugit autem.

Rem repellendus saepe optio quae. Est fugit sequi velit autem qui porro cupiditate optio. Pariatur sint sunt quos non voluptatem aut ut. Quia maxime incidunt et deleniti.

Career Advancement Opportunities

July 2026 Hedge Fund

  • Point72 99.0%
  • D.E. Shaw 98.1%
  • Citadel Investment Group 97.1%
  • AQR Capital Management 96.2%
  • Magnetar Capital 95.2%

Overall Employee Satisfaction

July 2026 Hedge Fund

  • Magnetar Capital 99.0%
  • D.E. Shaw 98.0%
  • Blackstone Group 97.1%
  • Citadel Investment Group 96.1%
  • Millennium Partners 95.1%

Professional Growth Opportunities

July 2026 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 98.1%
  • D.E. Shaw 97.1%
  • Citadel Investment Group 96.2%
  • Magnetar Capital 95.2%

Total Avg Compensation

July 2026 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (27) $464
  • Director/MD (12) $423
  • NA (9) $320
  • Engineer/Quant (86) $288
  • 3rd+ Year Associate (26) $284
  • Manager (4) $282
  • 2nd Year Associate (32) $253
  • 1st Year Associate (77) $191
  • Analysts (242) $181
  • Intern/Summer Associate (29) $145
  • Junior Trader (5) $102
  • Intern/Summer Analyst (282) $96
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”